{"doi":"10.1126/scitranslmed.abn3353","title":"B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?","abstract":"<jats:p>Chimeric antigen receptor (CAR) T cell therapies targeting CD19 and CD22 have been successful for treating B cell cancers, but CAR T cells targeting non–B cell cancers remain unsuccessful. We propose that rather than being strictly a side effect of therapy, the large number of CAR interactions with normal B cells may be a key contributor to clinical CAR T cell responses.</jats:p>","journal":"Science Translational Medicine","year":2022,"id":599796,"datarank":0.4636563680037475,"base_score":3.091042453358316,"endowment":3.091042453358316,"self_citation_contribution":0.4636563680037475,"citation_network_contribution":0.0,"self_endowment_contribution":0.4636563680037475,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":21,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":325454,"name":"J. Joseph Melenhorst","orcid":"0000-0001-7677-537X","position":1,"is_corresponding":false},{"id":225110,"name":"Kai Tan","orcid":"0000-0002-9104-5567","position":2,"is_corresponding":false},{"id":496140,"name":"Gregory M. Chen","orcid":"0000-0002-4083-5083","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?","abstract":"<jats:p>Chimeric antigen receptor (CAR) T cell therapies targeting CD19 and CD22 have been successful for treating B cell cancers, but CAR T cells targeting non–B cell cancers remain unsuccessful. We propose that rather than being strictly a side effect of therapy, the large number of CAR interactions with normal B cells may be a key contributor to clinical CAR T cell responses.</jats:p>","is_dataset_classified":null,"base_score":3.091042453358316,"endowment":3.091042453358316,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"35731887","pmcid":"PMC9284935","openalex_id":"https://openalex.org/W4283270985","authors":[],"funders":[{"funder_name":"CIHR","grant_id":"433117 ","title":null},{"funder_name":"NCI NIH HHS","grant_id":"U01 CA243072","title":null},{"funder_name":"NCI NIH HHS","grant_id":"U2C CA233285","title":null},{"funder_name":"NCI NIH HHS","grant_id":"U01 CA232361","title":null},{"funder_name":"Canadian Institutes of Health Research","grant_id":"unidentified","title":"unidentified"},{"funder_name":"European Commission","grant_id":"233285","title":"Discovery of Type 2 Diabetes Targets"},{"funder_name":"National Institutes of Health","grant_id":"1U01CA232361-01A1","title":"Defining and overcoming intrinsic T cell dysfunction to enable pediatric immunotherapy"},{"funder_name":"National Institutes of Health","grant_id":"5U2CCA233285-02","title":"Center for pediatric tumor cell atlas"},{"funder_name":"National Institutes of Health","grant_id":"5U01CA243072-05","title":"Towards rational design of combination therapeutic targets"}],"total_grants":9,"fwci":1.6733,"citation_percentile":0.8635457,"influential_citations":0,"citation_trend":[{"year":2023,"count":3},{"year":2024,"count":5},{"year":2025,"count":10},{"year":2026,"count":3}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9284935","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9284935","host_type":"repository"},{"url":"https://www.science.org/doi/pdf/10.1126/scitranslmed.abn3353","host_type":"publisher"},{"url":"https://doi.org/10.1126/scitranslmed.abn3353","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/35731887","host_type":"repository"}],"fields_of_study":["CAR-T cell therapy research","Virus-based gene therapy research","Viral Infectious Diseases and Gene Expression in Insects","0301 basic medicine","03 medical and health sciences","0302 clinical medicine","Antigens, CD19","B-Lymphocytes","Drug-Related Side Effects and Adverse Reactions","Humans","Immunotherapy, Adoptive","Receptors, Antigen, T-Cell","T-Lymphocytes"],"mesh_terms":["B-Lymphocytes","Humans","Receptors, Antigen, T-Cell","T-Lymphocytes","Immunotherapy, Adoptive","Antigens, CD19","Drug-Related Side Effects and Adverse Reactions"],"keywords":["Chimeric antigen receptor","CD19","CAR T-cell therapy","T cell","Cell","B cell","Cancer research","Cell therapy","Medicine","Antigen","Immunology","Biology","Immune system","Antibody","Genetics","B-Lymphocytes","Drug-Related Side Effects and Adverse Reactions","T-Lymphocytes","Antigens, CD19","Receptors, Antigen, T-Cell","Humans","Immunotherapy, Adoptive"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-29T11:16:13.018619Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}